financetom
Business
financetom
/
Business
/
What's Going On With IonQ Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With IonQ Stock Today?
Apr 1, 2025 5:27 AM

IonQ, Inc. ( IONQ ) shares are trading higher in the premarket session on Tuesday following the announcement of a significant milestone in quantum computing.

The company has officially made its flagship quantum computer, IonQ Forte Enterprise, available to global customers through Amazon Braket and the IonQ Quantum Cloud.

Amazon Braket is a fully managed AWS service that helps researchers, scientists, and developers start using quantum computing. 

The collaboration with AWS allows customers worldwide to access the cutting-edge IonQ Forte Enterprise, a quantum system capable of #AQ36 performance.

This advancement opens new possibilities for industries such as life sciences, financial services, manufacturing, and pharmaceuticals to leverage quantum computing for solving complex challenges and creating real-world impact.

Also recently, Benchmark analyst David Williams reiterated IonQ ( IONQ ) with a Buy and $45 price forecast.

Also Read: China’s XPeng Clocks Record Q1 EV Sales, Deliveries Surge 3.6X

Niccolo de Masi, President and CEO of IonQ ( IONQ ), highlighted that the goal of the launch is to bring quantum technologies into the hands of developers, enabling them to create innovative commercial applications.

“IonQ’s goal is to get our quantum technologies into the hands of developers so they can build and develop new commercial applications to solve some of today’s most complex problems,” Masi added.

IonQ Forte Enterprise is designed with a rack-mounted form factor and optimized for energy efficiency and modern data center environments. The move builds on previous successes, such as Ansys using IonQ Forte to enhance the design of life-saving medical devices.

With this global availability, IonQ ( IONQ ) continues to expand its global data center footprint, which now includes Washington, D.C., Seattle, and Basel, Switzerland.

According to Benzinga Pro, IONQ ( IONQ ) stock has gained over 120% in the past year. Investors can gain exposure to the stock via Defiance Daily Target 2X Long IONQ ETF ( IONX ) .

Price Action: IONQ ( IONQ ) shares are trading higher by 1.86% to $22.48 premarket at last check Tuesday.

Also Read:

AMD Powers Oracle Cloud With New Epyc Chips Promising Major Boost In Performance

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Iamgold to Acquire Mines D'Or Orbec for $17.2 Million
Iamgold to Acquire Mines D'Or Orbec for $17.2 Million
Oct 20, 2025
08:12 AM EDT, 10/20/2025 (MT Newswires) -- Iamgold ( IAG ) said Monday it has agreed to acquire Mines D'Or Orbec in a cash and stock deal valued at about $17.2 million Canadian dollars ($12.3 million). Under the deal, each Mines D'Or Orbec shareholder will receive CA$0.0625 in cash and 0.003466 of an Iamgold ( IAG ) share for a...
Iraq bans US gaming platform Roblox over child safety concerns
Iraq bans US gaming platform Roblox over child safety concerns
Oct 20, 2025
BAGHDAD, Oct 20 (Reuters) - Iraq has banned U.S. user-generated videogame platform Roblox ( RBLX ) due to concerns over child abuse, the government said, joining other countries in cracking down on virtual worlds. The government said late on Sunday that the ban was motivated by concerns that the game allowed direct communication between users in ways that exposed children...
AbbVie's Rinvoq shows superiority over Humira in head-to-head study
AbbVie's Rinvoq shows superiority over Humira in head-to-head study
Oct 20, 2025
Oct 20 (Reuters) - AbbVie ( ABBV ) said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, meeting the main goal of a head-to-head trial. (Reporting by Puyaan Singh in Bengaluru) ...
Disc Medicine Provides Update on Cash Position, Hematology Portfolio
Disc Medicine Provides Update on Cash Position, Hematology Portfolio
Oct 20, 2025
08:13 AM EDT, 10/20/2025 (MT Newswires) -- Disc Medicine ( IRON ) said Monday it ended Q3 with about $616 million in cash, cash equivalents and marketable securities. On Aug. 7, the company reported that it ended Q2 with $650 million in cash and equivalents. Among drugs in development, Disc Medicine ( IRON ) said it expects to report initial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved